I
Immunocore Holdings plc
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of Immunocore Holdings plc
Revenue$249M▲ 43.1% YoYFY 2023
Operating income−$59.6M▼ 15.4% YoY
Net profit−$55.3M▼ 5.2% YoY
Shareholders' equity$369M
Market cap$1.5BIMCR · $29.79
Competitors10identified
About Immunocore Holdings plc
Sectors
Company details
- Founded
- 2021
- Listed
- Nasdaq: IMCR (since 2021)
Operational Areas of Immunocore Holdings plc
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameImmunocore Holdings plc
TickerIMCR
ExchangeNasdaq
CountryUnited Kingdom
SEC CIK0001671927
Listed since2021
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
IMCR · Nasdaq · SEC CIK 0001671927
Last price · 03 Nov 2026
$29.79
−2.30%
Market cap$1.5B
P/E—On FY 2023 diluted EPS
Volume226,070
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited KingdomListed 2021
IMCR share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Immunocore Holdings plc
Competitors10identified
Countries1most in United Kingdom
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Part of Abcam. | abcam.com/en-us | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | abcodia.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | diabetology.co.uk | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | genusplc.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | selectbiosciences.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | vernalis.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | oxitec.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | horizondiscovery.com | — | United Kingdom | |
| Part of Immunocore. | immunocore.com | — | United Kingdom |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.